Valuation & Market

A new ACORD study reveals a seismic shift in insurance M&A. The old 'bigger is better' approach now destroys value, while strategic deals thrive.

The extended partnership solidifies the two giants' grip on the VR market, promising new tools for developers and accelerating VR's push beyond gaming.

The testing giant acquires a mission-critical specialist, diving into the booming data center and semiconductor markets fueled by artificial intelligence.

For decades, toxic chemicals were the norm in HVACR. See how one family business's commitment to safety led to explosive growth and industry-wide change.

GA Group's strategic acquisition of G2 Capital Advisors creates a full-lifecycle advisory and investment banking platform for the middle market.

Following a string of 14 acquisitions, IMS Legal Strategies is sold. The deal highlights major trends in private equity and the future of legal services.

As PharmaCorp Rx prepares for a key investor conference, its strategy of consolidating independent pharmacies faces a pivotal test of market confidence.

Activist investor Maven Investment Partners is rallying shareholders against Bain Capital's tender offer for MCJ, calling the bid 'unacceptably short'.

Investors eye Amerant Bancorp's Q1 results for signs of a turnaround after a challenging Q4 and a recent leadership change. Will its new strategy pay off?

NewBeauty's 16th annual awards spotlight 395 winners, signaling a major shift towards science-backed efficacy and holistic health in the beauty market.

Longhorn Diagnostics unveils LHNVD-501, a novel antibody targeting a universal bacterial component, offering a new front against AMR and chronic inflammation.

The diagnostics firm posts strong thyroid growth after a strategic shift, but a one-time tax adjustment inflates its impressive 2025 bottom line.

PMGC Holdings touts major acquisitions and a promising biotech pipeline, but a look at its financials reveals a high-stakes bet on future growth.

As co-founder Jürgen Bickel steps down, 14-year veteran David Männer takes the helm to navigate Storz & Bickel's future and drive Canopy's U.S. plans.

With near-zero revenue and a history of pivots, 1606 Corp. is betting its future on solving AI's energy crisis. Can it pull off this risky venture?

Adhesives giant H.B. Fuller expands margins and raises its 2026 outlook, signaling operational strength amid market softness and supply chain turmoil.

Hyperliquid Strategies' PURR stock now has options on Nasdaq, offering new ways to invest in the booming DeFi world, but not without significant risks.

The shipping firm is buying back up to 1 million shares at $3.00 each, a massive premium over its current market price, signaling deep undervaluation.

Israel's kosher food giant rewards shareholders with a hefty dividend, backed by record profits and demonstrating resilience in a volatile global market.

The homesite developer declared a $0.76 quarterly dividend, showcasing a resilient model that thrives by offering builders an asset-light land strategy.